Introduction
The nikkomycins, a complex of structurally closely related nucleoside-peptide antibiotics from Strep tom yces tendae Tii 901, are potent inhibitors of chitin synthases from fungi and insects [1] [2] [3] [4] [5] [6] . All biologi cally active nikkomycins posses a modified nucleo side moiety linked by a peptide bond to the uncom mon amino acid hydroxypyridyl-homothreonine (HPHT) (Fig. 1) . The investigations presented in this paper are re lated to the biosynthesis of 4-formyl-4-imidazoline-2-on, the heterocyclic base of the nikkomycins X, I and M [3] , On principle there exist three possibilities which could explain the biogenetic origin of the base ( Fig. 2 ):
1. 4-Formyl-4-imidazoline-2-on is derived from the biosynthetic pyrimidine nucleotide metabolism by a rearrangem ent of uracil, similar to a reaction propos ed by U ram oto et al. [10] for the biosynthesis of 2. The base is derived from the biosynthetic histi dine metabolism. If this assumption is correct then the ring carbons should originate from C-atoms 1 and 2 of ribose and C-atom 2 (but not 8) of adenine or from the imidazole ring of histidine, respectively.
3. An interm ediate of the purine nucleotide bio synthetic pathway represents the precursor of 4-formyl-4-imidazoline-2-on. This implies that carbons 4 and 5 of the base should be derived from glycine, and C-2 should originate from C-8 of adenine.
In order to test w hether one of these hypotheses is correct, incorporation experim ents with different 14C-and l3C-labeled precursors were perform ed. 
Organism s and culture conditions
Streptom yces tendae Tü 901 (a gift from H. Z ähner, Tübingen) was grown in the following m edium (75 ml in a 500 ml baffled flask): 3% mannitol, 1% starch, 1% yeast extract, 0,5% soy pep tone, tap water. A fter incubation (28 °C) on a gyrotory shaker for 68 hours, the mycelium was harvested and washed with tap water by centrifugation. The cells were resuspended in tap w ater; the volume of this suspension was 50% of the volume claimed by the original culture. 10 ml of this cell suspension were transferred to 20 ml resting cell medium (21 mM 3,3'-dim ethylglutaric acid, 0.67% m annitol, 4.3 m M NH4NO3, 2.7 m M M gS 04 in tap water, pH 6.0 adjusted with N a O H ) located in a 100 ml baf fled flask. This culture was incubated at 28 °C on a gyrotory shaker (160 rpm ).
Incorporation experiments
[2-14C] Adenine (specific radioactivity 51 mCi/mmol or 0.14 mCi/mmol, respectively; see Table I [2-13C]adenine (90% enriched) was added to a fi nal concentration of 0.5 m M in the resting cell cul ture.
A fter incubation for 24 to 48 hours, the mycelium was removed by centrifugation.
Concentration of biologically active nikkomycins was determ ined by plate diffusion assay with M ucor hiemalis Tü 179 according to [1] .
Isolation o f nikkom ycin X 1. Incorporation experim ents with 14C-labelled precursors: A fter acidification to pH 4.0 cell-free culture fluid (1-2 cultures) was applied to SPSephadex C-25 (pyridinium form , 2 x 2 0 cm). E lu tion of nikkomycins was carried out with a discon tinuous gradient of pyridine acetate buffer pH 4.7 (10, 20, 30, 40 , and 50 mM). Fractions containing biologically active nikkomycins (eluted with 50 mM buffer) were pooled and lyophilized after determ ina tion of radioactivity. The lyophilisate was redissolved in 0.1% acetic acid, and the different nikkomycins were separated by preparative HPLC (RP-18 col umn; 4.6 x 125 mm; Shandon Hypersil ODS 5 |a) ac cording to the method of Fiedler [9] .
2. Incorporation experim ents with [2-13C]adenine: Cell-free culture supernatant from 10 cultures con taining approx. 70 mg biologically active nikkomy cins was applied to a column of SP-Sephadex C-25 (pyridinium form, 3 x 35 cm). Nikkomycin was eluted with a discontinuous gradient consisting of 10, 30, 40 and 50 mM pyridine acetate buffer pH 4.7. Fractions containing nikkomycin were pooled and ly ophilized. The lyophilisate was redissolved in 0.1% acetic acid and chrom atographed several times on Biogel P-2 (200-400 mesh; 2.6 cm x 76 cm) equili brated with 0.1% C H 3C O O H . Flow rate was held at 14 ml/hr. Purified nikkomycin X was obtained with a yield of approx. 30%.
Isotope determ ination: Radioactivity was deter mined by liquid scintillation counting (Philipps PW 4700 scintillation spectrom eter). °C -N M R spectra of purified nikkomycin X (dissolved in D 20/DC1 pH 2.5) were recorded at 75 MHz with a B ruker WM 300 NMR spectrom eter. Mass spectrom etric investi gations were done by the static SIM S-method [7, 8] ; nikkomycin was dissolved in 0.1% acetic acid and applied on silver foil.
Results and Discussion
Ferm entative production and isolation of nik komycin: The resting cell medium used was de veloped by Sommer [20] who reported a maximal nikkomycin yield of approx. 200 mg/1 after 72 hours of incubation. By selecting for a high-producing wild type clone and increasing the oxygen transfer into the culture medium it was possible to increase the nikkomycin production of Streptom yces tendae up to 250-260 mg nikkomycin/1 after 48 hours of incuba tion.
The purification procedure used for the isolation of nikkomycin X did not yield a 100% homogenous substance; the product still contained a certain am ount of nikkomycin Z (6-10% as determ ined by H PLC). However, this degree of purity proved to give satisfactory results in 13C-NM R m easurements (Fig. 3) .
Incorporation o f I4C-labelled com pounds
To test the different hypotheses for the biogenetic origin of the nikkomycin X base 4-formyl-4-imidazoline-2-on (as summarized in Fig. 2) , adenine, glycine, histidine, and uracil labelled with 14C were adm inistered to cultures of S. tendae during nik komycin production. A fter isolation of the nikkomy cin complex by ion exchange chrom atography, nikkomycins X and Z were separated by HPLC. The labelling of the two different com pounds is shown in Table I .
Radioactivity from [2-14C ]adenine, [U-14C]L-histidine, and [2-14C]L-histidine is very effectively incor porated into the nikkomycins (incorporation rates
15%, 8% and 20% , resp.). These three compounds lead to a significantly higher specific radioactivity in nikkomycin X compared to nikkomycin Z (ratios 17:1 to 25:1). Glycine, the precursor of carbons 5 and 6 in adenine, is incorporated to a much lower extent (incorporation rate 1.7%) into the nikkomycin com plex; both, X and Z are nearly equally labelled by this amino acid. A similar results was obtained with [8-14C] adenine: a rather low incorporation of label (0.9% ) and no significant discrimination between nikkomycins X and Z. Uracil obviously is a very specific precursor of nikkomycin Z and not of the X isomer (specific radioactivity ratio X :Z = 1:46), ex cluding an earlier proposal for the biosynthesis of the neopolyoxins [10] .
These results imply that the unusual heterocyclic base of nikkomycin X is form ed via adenine Table I ) could sup port this assumption. If this holds true, C-2 of the histidine imidazole ring and C-2 of the "pyrimidine" ring of adenine should be the im m ediate precursors of C-2 in nikkomycin X. 
R (R ') -integral C /integral Cj r -R '/R .

Incorporation o f !3C-enriched adenine
Final proof for the assumption presented above was obtained by an experim ent with l3C-enriched adenine. The analysis of 13C-NM R spectra -accom plished according to Rathm ann [11] and Sommer [20] -showed that unequivocal signal assignment is possible even if the nikkomycin X preparation does contain small amounts of the other nikkomycins in cluding Z (Fig. 3, Table II) . A fter incorporation of [2-13C] adenine (90% enriched) only the signal at 156.4 ppm (i.e. C-2 of the nikkomycin X base) had increased in intensity com pared to the natural abundance NM R spectrum (Fig. 3) . Using C -l' (i.e. the glycosidic carbon atom of the hexosaminuronic acid portion) as the reference signal, a specific incor poration into C-2 of the heterocyclic base was obvi ous; a 31 fold enrichm ent was calculated (Table II, Fig. 3 ; calculation of incorporation rate according to Wright et al. [12] ).
Mass spectrom etric studies (SIMS) with nikkomy cin X gave the following results: the fragm ent with m /z = 111 represents the formylimidazoline moiety. If the relative intensity of this signal is set as 100%, the relative intensity of the fragm ent m /z = 112 in creases from 11.6% (nikkomycin with natural abun dance 13C content) to 27.1% in nikkomycin obtained after incorporation of [2-13C] adenine. A specific in corporation of 15 -16% is calculated from these data.
The difference between the results obtained by NMR m easurement and mass spectrom etry is at least partly due to the fact that the 13C-enriched nikkomy cin preparation contained a small am ount (approx. 9% ) of nikkomycin Z. W hereas the NM R m ethod discriminates between the two isomers (C-2 of 4-formyl-4-imidazoline-2-on in nikkomycin X at 156.4 ppm, C-2 of uracil in nikkomycin Z at Table III N evertheless the results show quite clearly that the 4-formyl-imidazoline base of nikkomycin X is biogenetically derived from adenine via the histidine biosynthetic pathway (see Fig. 2 ). Histidine itself ap pears to be an immediate precursor. Concerning the biochemical reactions leading from histidine to 4-formyl-4-imidazoline-2-on, only speculations are possi ble presently. Known reactions in histidine m etabol ism which could initiate a partial degradation of this
